A clinical risk model predicts over 300 ILD-free days in urological cancer patients on immune checkpoint inhibitors [0.03%]
一个临床风险模型可以预测泌尿系统肿瘤患者在接受免疫检查点抑制剂治疗时超过300天不发生间质性肺病
Shinro Hata,Satoki Abe,Hiroyuki Fujinami et al.
Shinro Hata et al.
Background: Immune checkpoint inhibitor (ICI)-induced interstitial lung disease (ILD) is a potentially fatal complication, yet practical risk stratification tools integrating systemic inflammatory markers and pre-existing...
End-of-life cancer care quality in rural areas of Japan: an exploratory bereaved family survey [0.03%]
日本农村地区临终癌症护理质量:一项丧亲家庭调查的探索性研究
Richi Takahashi,Yoko Nakazawa,Saho Wada et al.
Richi Takahashi et al.
Introduction: Palliative care is essential for people with life-threatening illness, yet access remains inequitable in many rural areas. In Japan, rural disparities in end-of-life (EOL) cancer care have not been well desc...
Influence of pathologic fractures on oncologic outcomes in extremity Ewing sarcoma: a single-institution retrospective study [0.03%]
肢体尤因肉瘤病理性骨折对肿瘤预后影响的单中心回顾性研究
Hisaki Aiba,Ayano Aso,Alberto Righi et al.
Hisaki Aiba et al.
Background: Pathologic fractures occur in 5%-10% of patients with Ewing sarcoma and may influence the local treatment strategies. However, their prognostic impact remains unclear. This study evaluated the clinical course ...
Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility [0.03%]
恩沃单抗联合帕博利珠单抗用于晚期尿路上皮癌一线治疗的短期疗效和安全性:无论是否适合顺铂治疗
Takuji Hayashi,Atsunari Kawashima,Yoshiyuki Yamamoto et al.
Takuji Hayashi et al.
Objective: This study aimed to evaluate the short-term efficacy and safety of enfortumab vedotin plus pembrolizumab (EV + P) as a first-line systemic therapy for patients with advanced urothelial carcinoma (UC) in real-wo...
Nomogram of conditional survival probability in oldest old patients with colorectal cancer after surgical resection: a multicenter retrospective cohort study [0.03%]
接受手术切除的超高龄结直肠癌患者术后条件生存概率列线图:一项多中心回顾性队列研究
Kiyoaki Sugiura,Eiki Sato,Junya Aoyama et al.
Kiyoaki Sugiura et al.
Background: Prognostic models for oldest old patients with colorectal cancer (CRC) are needed to inform treatment decision-making. We aimed to develop a conditional survival (CS) nomogram tailored specifically to this pat...
Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world study [0.03%]
达尔olutamide联合多西他赛治疗转移性雄激素敏感性前列腺癌的三联疗法:一项多中心真实世界研究
Ibuki Tsuru,Satoru Taguchi,Ryo Tanaka et al.
Ibuki Tsuru et al.
Background: Triplet therapy with darolutamide and docetaxel has reshaped the treatment landscape of metastatic castration-sensitive prostate cancer (mCSPC). However, real-world evidence regarding its oncological outcomes ...
Characterization of distant metastases in salivary gland cancer patients undergoing upfront surgery followed by postoperative radiation therapy: a multicenter analysis [0.03%]
腮腺癌患者初次手术后接受术后放疗的远处转移特征:多中心分析
Dong Soo Lee,Min Kyu Kang,Chang Geol Lee et al.
Dong Soo Lee et al.
Background: This study aimed to clarify the incidence and outcomes of distant metastasis (DM) in patients with major salivary gland cancer who received upfront surgery followed by adjuvant postoperative radiation therapy....
A Lynch syndrome patient with multiple cancers who was found to have a novel pathogenic variant generating aberrant splicing of MLH1 [0.03%]
一个患有林奇综合征并伴有多种癌症的病人被发现MLH1产生异常剪接的新型致病突变
Ayumi Abe,Hidetaka Eguchi,Kimio Matsumura et al.
Ayumi Abe et al.
Lynch syndrome is an autosomal dominant cancer predisposition syndrome caused by inactivating germline variants in DNA mismatch repair genes. Here, we describe a woman who developed colorectal, gastric, and endometrial cancers and was found...
Age-standardized mortality-to-incidence ratio for lymphoma in the world [0.03%]
全球淋巴瘤患者年龄标准化发病率和死亡率之比
Kumiko Saika,Laureline Gatellier
Kumiko Saika